| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |